Sleepwalking [somnambulism]

F5_SLEEPWALKING

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F51.3 Cause of death: ICD-10 — F51.3 2 out of 7 registries used, show all original rules.	98
4. Check minimum number of events None	98
5. Include endpoints None	98
6. Filter based on genotype QC (FinnGen only)	98

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	F5_SLEEPWALKING
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F513
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F513
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleepwalking [somnambulism] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	741	345	395
Only index persons	706	334	372
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	24.02	29.30	19.39
Only index persons	24.31	29.66	19.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	98	69	29
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	34.44	37.36	27.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
84: Matched controls
838

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

+∞

120.9

G47.9

ICD-10 Finland

Sleep disorder, unspecified

40.2

15.6

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

34.5

9.7

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

+∞

9.5

N03AE01

ATC

clonazepam; systemic

11.7

7.9

N06AX11

ATC

mirtazapine; oral

3.6

6.5

143

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

+∞

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42870588) Differential panel, method unspecified - Blood

239

2.33

3.93

4.4

5.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

9.31

3.84

1.1

1.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

245

2.25

3.66

1.7

1.8

103.0

97.3

pmol/l

0.31

130

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

232

2.22

3.50

3.4

2.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

4.01

3.45

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

3.86

3.29

1.0

1.1

—

(3000492) Spirometry study

2.67

3.23

1.4

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

3.73

3.14

1.0

1.2

—

(3018095) Leukocytes [#/volume] in Urine

259

2.09

3.07

3.7

3.1

23.0

47.0

e6/l

0.49

175

(3025941) Bacteria identified in Stool by Culture

3.11

3.05

1.3

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

214

2.08

2.87

3.3

2.5

11.2

75.7

e6/l

1.42

163

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

311

1.98

2.77

2.1

2.4

72.7

71.7

nmol/l

0.10

284

(40768804) Tissue Pathology biopsy report

311

1.98

2.77

1.7

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

6.31

2.74

1.2

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.97

2.65

1.3

1.7

—

(40758558) Short blood count panel - Blood

187

2.06

2.64

7.1

6.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

7.45

2.58

1.0

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

491

1.96

2.51

4.7

4.1

—

39.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

121

2.18

2.47

2.3

2.1

1.8

0.8

e6/l

—

(3021589) Normoblasts [#/volume] in Blood

349

1.88

2.43

6.7

7.9

0.0

e9/l

0.00

289

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

234

1.93

2.42

1.5

1.3

1.2

u/ml

0.07

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2.50

2.38

2.8

1.8

319.4

4893.0

u/l

—

(3000991) Gas panel - Venous blood

3.07

2.38

21.9

10.0

—

(3030467) Casts [#/volume] in Urine by Automated count

197

1.93

2.25

3.4

2.5

0.3

0.1

e6/l

0.51

143

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

5.78

2.24

1.0

—

(3013115) Eosinophils [#/volume] in Blood

404

1.82

2.21

6.3

6.1

0.2

e9/l

0.06

367

(3006315) Basophils [#/volume] in Blood

389

1.79

2.10

6.3

5.7

0.0

e9/l

0.04

351

(3001604) Monocytes [#/volume] in Blood

389

1.79

2.10

6.3

5.7

0.5

e9/l

1.27

351

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

5.20

2.09

1.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

114

2.07

2.3

2.2

4.9

2.8

e6/l

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

4.19

2.07

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

683

2.07

2.00

4.0

3.4

5.8

5.6

mmol/l

0.74

639

(36304419) Bacteria [Presence] in Urine

204

1.84

2.00

3.5

2.4

—

(3015736) pH of Urine

310

1.76

1.97

3.6

2.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

535

1.80

1.92

3.8

4.1

—

(40761535) Cells panel - Urine sediment

2.67

1.90

5.0

2.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

199

1.82

1.88

2.1

2.8

11.8

67.7

ng/l

0.97

(40768797) Stomach Pathology biopsy report

2.10

1.84

1.3

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

209

1.79

1.83

1.4

1.3

2.2

2.1

g/l

0.01

118

(3021601) Nitrite [Presence] in Urine by Test strip

381

1.71

1.82

5.2

4.5

0.0

estimate

0.00

(3003327) Ova and parasites identified in Stool by Light microscopy

2.60

1.82

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

160

1.85

1.80

1.5

2.0

0.6

0.7

mg/l

0.26

114

(40761511) CBC panel - Blood by Automated count

850

2.84

1.79

10.4

9.5

—

(3011288) Drugs identified in Urine by Screen method

2.26

1.75

2.0

1.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

2.72

1.70

1.4

7.5

4.9

7.1

mmol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

257

1.71

1.70

2.4

2.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

3.29

1.69

1.3

1.2

0.3

2.2

e6/l

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3.29

1.69

1.3

1.7

0.6

—

(3009261) Glucose [Presence] in Urine by Test strip

388

1.66

1.65

4.2

3.1

0.0

estimate

0.00

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.63

1.63

2.1

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

3.70

1.63

1.2

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.70

1.63

1.0

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2.06

1.60

1.7

2.8

3.3

4.8

umol/l

1.04

(3022145) Colonoscopy Study observation

2.03

1.55

1.1

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

3.45

1.54

1.2

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

3.45

1.54

1.4

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.97

1.53

1.3

1.9

0.9

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2.61

1.48

1.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

808

2.10

1.48

13.7

10.5

19.2

21.9

mg/l

0.31

611

(3044889) 12 lead EKG panel

437

1.59

1.42

3.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

259

1.62

1.41

3.1

2.9

22.9

28.6

u/l

1.78

242

(3032080) INR in Blood by Coagulation assay

198

1.66

1.39

1.9

6.1

1.0

1.1

inr

2.55

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.02

1.36

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

454

1.54

1.28

9.6

8.0

3.6

4.1

e9/l

1.92

402

(3035350) Ketones [Presence] in Urine by Test strip

386

1.54

1.27

4.2

3.0

0.0

estimate

0.00

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

567

1.57

1.25

3.5

2.7

29.0

35.2

u/l

0.97

545

(3011397) Hemoglobin [Presence] in Urine by Test strip

160

1.66

1.25

4.5

3.0

—

(3012516) Albumin [Mass/volume] in Urine

135

1.71

1.24

3.6

3.4

9.4

124.0

mg/l

1.26

(3023368) Bacteria identified in Blood by Culture

152

1.67

1.23

4.2

4.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

144

1.68

1.22

1.8

2.7

288.1

3057.4

umol/l

0.50

130

(3002385) Erythrocyte distribution width [Ratio]

721

1.71

1.18

14.4

12.5

13.3

0.18

713

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

722

1.70

1.17

10.8

9.2

95.4

96.4

ml/min/173m2

0.16

553

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.43

1.15

1.0

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.93

1.15

3.1

2.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2.35

1.13

1.0

1.1

—

(3000494) Fungus identified in Specimen by Culture

1.83

1.12

1.3

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

106

1.73

1.12

1.3

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

166

1.59

1.08

1.9

2.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2.21

1.08

1.3

2.1

40.1

126.8

ng/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.21

1.08

1.9

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

238

1.51

1.05

2.4

2.3

—

(36660697) Celiac disease serology panel - Serum

1.74

1.04

1.3

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

315

1.46

0.99

2.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

119

1.63

0.96

1.7

2.1

—

(3029937) Albumin [Presence] in Urine by Test strip

197

1.51

0.96

5.3

2.9

0.0

estimate

0.00

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.22

0.93

1.2

1.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.76

0.90

2.4

1.4

—

(3002032) Base excess in Venous blood by calculation

1.80

0.85

1.5

1.7

0.0

2.6

mmol/l

—

(21494755) Public health laboratory ask at order entry panel

121

0.55

0.85

1.0

1.3

—

(3045414) Leukocytes [Presence] in Urine

1.93

0.83

1.3

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.72

0.81

1.1

—

(3012544) pH of Venous blood

1.72

0.81

1.5

2.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

142

1.51

0.80

3.9

4.0

1.0

15.3

mg/mmol

1.35

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.68

0.79

1.3

2.1

373.7

399.1

nmol/l

0.25

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

100

1.59

0.78

1.5

1.8

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2.14

0.75

41.6

14.3

0.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2.14

0.75

41.6

14.3

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2.05

0.74

1.4

23.8

24.6

mmol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

254

1.39

0.73

2.1

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.67

0.72

1.5

—

(1002224) Polysomnography panel

1.76

0.71

1.0

1.1

—

(3013512) EKG study

146

1.46

0.71

2.4

3.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

129

1.48

0.70

1.3

52.6

7.1

u/ml

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

749

1.47

0.69

4.0

3.5

2.7

2.8

mmol/l

0.65

708

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.62

0.65

1.5

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

785

1.49

0.64

16.3

11.4

40.5

40.6

0.09

656

(3023511) Choriogonadotropin [Units/volume] in Urine

1.65

0.63

1.3

1.2

—

(3022621) pH of Urine by Test strip

1.62

0.62

1.6

2.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.59

0.62

2.5

5.5

1.0

mmol/l

0.07

(40768793) Breast Pathology biopsy report

0.00

0.60

0.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

714

1.37

0.57

3.2

3.1

1.1

1.2

mmol/l

1.43

674

(3003694) ABO and Rh group [Type] in Blood

287

0.74

0.56

1.8

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.51

0.55

1.1

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

1.57

0.54

1.5

1.6

—

(3026008) Bacteria identified in Urine by Culture

211

1.32

0.51

2.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1.47

0.49

1.5

1.7

1151.7

1067.5

nmol/l

0.14

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.52

0.49

1.4

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

741

1.34

0.49

3.6

3.3

1.5

mmol/l

0.10

700

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

112

1.40

0.48

2.0

3.5

8.5

32.0

ng/l

—

(3002256) Pathology report gross observation

1.45

0.47

1.1

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.42

0.46

2.1

3.7

0.8

mmol/l

0.05

(40760892) CBC W Ordered Manual Differential panel - Blood

196

1.30

0.45

5.5

4.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.49

0.44

1.9

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

301

1.25

0.44

4.9

2.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1.39

0.42

4.8

3.5

—

0.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

746

1.30

0.42

3.7

3.3

4.5

4.7

mmol/l

0.83

708

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.54

0.42

1.0

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.41

0.0

4.1

—

3.9

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.41

0.0

4.1

—

52.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

152

1.31

0.41

1.8

2.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

0.00

0.40

0.0

4.3

—

22.3

—

(3042936) Bacteria identified in Isolate by Culture

1.40

0.40

3.3

2.6

—

(40761536) Microorganisms panel - Urine sediment

1.36

0.39

4.4

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.36

0.39

1.3

1.4

—

(4010399)

1.49

0.37

2.2

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.68

0.35

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

731

1.25

0.34

4.4

3.9

—

(3027008) Opiates [Presence] in Urine

1.37

0.33

1.3

1.4

—

(3028300) Cannabinoids [Presence] in Urine

1.37

0.33

1.3

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

1.35

0.31

1.3

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

224

1.22

0.31

2.3

2.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.32

0.31

1.3

1.5

—

(3016879) Cocaine [Presence] in Urine

1.30

0.23

1.3

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.20

0.22

1.2

2.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.21

0.0

3.5

—

5.0

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.21

0.0

3.5

—

9.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.21

0.0

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.2

—

(1616796) Gas panel - Central venous blood

0.00

0.21

0.0

1.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

3.8

—

149.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

2.8

—

17.6

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.21

0.0

2.5

—

16.6

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.21

0.0

2.3

—

6.5

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.21

0.0

2.3

—

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.21

0.0

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

378

0.88

0.18

3.6

4.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.18

0.18

1.3

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.79

0.16

1.5

1.6

—

(3027944) Amphetamines [Presence] in Urine

1.21

0.14

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

172

1.13

0.12

1.4

1.5

—

(3003338) MCHC [Mass/volume]

741

1.11

0.12

18.4

12.7

332.0

333.7

g/l

0.93

736

(3041096) Erythrocytes [Presence] in Urine by Automated

241

1.11

0.12

3.5

2.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.14

0.10

1.2

1.5

—

(3019225) pH of Specimen

1.07

0.09

1.2

5.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

107

1.14

0.09

2.3

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

156

1.11

0.08

1.4

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1.04

0.08

4.3

1.4

271.8

252.2

mu/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.04

0.08

1.5

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

192

0.92

0.06

2.1

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

220

1.06

0.04

1.7

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

127

0.94

0.02

1.3

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

104

1.06

0.01

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

254

1.03

0.00

1.5

1.7

—

(1761868) Lipid panel - Serum or Plasma

313

0.99

0.00

1.9

2.3

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.0

2.3

—

57.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.0

7.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

2.4

—

3.9

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

2.4

—

106.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.0

2.9

—

89.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

2.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

0.0

2.8

—

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.97

0.00

5.8

4.7

—

(3010503) CD19 cells [#/volume] in Blood

0.00

0.0

1.4

—

0.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

10.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.87

0.00

1.2

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

0.0

1.0

—

7.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

0.00

0.0

1.4

—

83.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.2

—

39.7

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.87

0.00

1.2

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

3.0

—

99.8

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.0

1.4

—

(3025159) Blasts/100 leukocytes in Blood

1.00

0.00

6.3

3.6

—

0.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.1

—

32.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

1.5

—

(3008898) HLA-B27 [Presence]

0.87

0.00

1.6

1.1

—

(44806071)

0.00

0.0

1.2

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

2.0

—

(4146454)

0.00

0.0

2.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.87

0.00

1.2

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

1.5

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.87

0.00

1.2

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.0

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

2.8

—

972.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.3

—

5.8

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

2.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

9.3

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SLEEPWALKING and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_SLEEPWALKING.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: F5_SLEEPWALKING – Sleepwalking [somnambulism]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sleepwalking [somnambulism]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints